Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy VistaGen Therapeutics (VTGN) stocks
Learn how to easily invest in VistaGen Therapeutics stocks.
VistaGen Therapeutics is a biotechnology business based in the US. VistaGen Therapeutics stocks (VTGN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.77 – the same closing value as a week prior. VistaGen Therapeutics employs 32 staff and has a market cap (total outstanding stock value) of $28.9 million.
How to buy VistaGen Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – VTGN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in VistaGen Therapeutics?
- Has coronavirus impacted VistaGen Therapeutics shares?
- VistaGen Therapeutics shares summary
- Compare share dealing platforms
- Is VistaGen Therapeutics stock a buy or sell?
- VistaGen Therapeutics performance over time
- VistaGen Therapeutics's financials
- How volatile are VistaGen Therapeutics shares?
- Does VistaGen Therapeutics pay a dividend?
- Have VistaGen Therapeutics shares ever split?
- Other common questions
VistaGen Therapeutics stock price (NASDAQ:VTGN)Use our graph to track the performance of VTGN stocks over time.
VistaGen Therapeutics shares at a glance
|Latest market close||$0.13|
|52-week range||$0.08 - $1.22|
|50-day moving average||$0.14|
|200-day moving average||$0.15|
|Wall St. target price||$0.20|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.32|
Buy VistaGen Therapeutics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy VistaGen Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
VistaGen Therapeutics price performance over time
Historical closes compared with the close of $0.13 from 2023-05-26
|1 week (2023-05-24)||0.13|
|1 month (2023-05-01)||-7.14%|
|3 months (2023-03-03)||-23.39%|
|6 months (2022-12-01)||-4.41%|
|1 year (2022-05-27)||N/A|
|2 years (2021-05-28)||-94.98%|
|3 years (2020-05-29)||0.4416|
|5 years (2018-05-31)||1.41|
VistaGen Therapeutics financials
|Operating margin TTM||17506.02%|
|Gross profit TTM||$1.1 million|
|Return on assets TTM||-66.24%|
|Return on equity TTM||-126.59%|
|Market capitalisation||$28.9 million|
TTM: trailing 12 months
VistaGen Therapeutics share dividends
We're not expecting VistaGen Therapeutics to pay a dividend over the next 12 months.
Have VistaGen Therapeutics's shares ever split?
VistaGen Therapeutics's shares were split on a 1:20 basis on 14 August 2014. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your VistaGen Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for VistaGen Therapeutics shares which in turn could have impacted VistaGen Therapeutics's share price.
VistaGen Therapeutics share price volatility
Over the last 12 months, VistaGen Therapeutics's shares have ranged in value from as little as $0.08 up to $1.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while VistaGen Therapeutics's is 1.0014. This would suggest that VistaGen Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
VistaGen Therapeutics overview
VistaGen Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also comprises PH10, a rapid-onset neuroactive nasal spray, which is in preparation for Phase 2B clinical development as a stand-alone treatment for major depressive disorder (MDD); and AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is in development in combination with oral probenecid as a potential treatment of levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. It has contract research and development agreement with Cato Research Ltd. ; license agreement with Pherin Pharmaceuticals, Inc.
Stocks similar to VistaGen Therapeutics
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Best bad credit loans in Prince Edward Island
Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
5 apps like Bree in Canada
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Debt Relief Canada (reliefcanada.ca) review
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Desjardins Online Brokerage (Disnat) review 2023
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.